| Trial ID: | L1699 |
| Source ID: | NCT05475431
|
| Associated Drug: |
The Sequential Therapy
|
| Title: |
Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity
|
| Acronym: |
Real-world_Hp
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Helicobacter Pylori Infection|Comorbidities and Coexisting Conditions|Real-world Outcome|Medication Adherence|Patient Compliance|Patient Dropouts
|
| Interventions: |
DRUG: The sequential therapy|DRUG: The triple therapy|DRUG: The hybrid therapy|DRUG: The concomitant therapy|DRUG: Bismuth-based quadruple therapy
|
| Outcome Measures: |
Primary: The eradication rate by the intention-to-treat analysis, Successful H. pylori eradication is confirmed by the 13C-urea breath test, rapid urease test, or H. pylori stool antigen test. All the reviewed patients are analyzed for intention-to-treat of H. pylori eradication., At least six weeks after the completion of H. pylori eradication|The eradication rate by the per-protocol analysis, Successful H. pylori eradication is confirmed by the 13C-urea breath test, rapid urease test, or H. pylori stool antigen test. Patients who do not complete the regimens or do not receive the confirmation of successful H. pylori eradication by the 13C-urea breath test, rapid urease test, or H. pylori stool antigen test are excluded from the per-protocol analysis., At least six weeks after the completion of H. pylori eradication |
|
| Sponsor/Collaborators: |
Sponsor: National Cheng-Kung University Hospital | Collaborators: Ministry of Health and Welfare, Taiwan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1053
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2020-05-06
|
| Completion Date: |
2023-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-07
|
| Locations: |
Helicobacter pylori study group, National Cheng Kung University Hospital, Tainan, 70403, Taiwan|National Cheng Kung University Hospital, Tainan, 704302, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT05475431
|
